Mindful Attention Training for Pediatric Cancer Survivors
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new attention training program called Novel Mindful Attention Training to determine if it improves thinking and behavior in children who have survived cancer. Participants will either engage in a detailed at-home training program, a shorter version, or have no contact with the training, allowing for result comparison. The trial suits children who received radiation therapy to the brain or neck and are not currently undergoing active cancer treatment. As an unphased trial, this study provides a unique opportunity for participants to contribute to innovative research that could enhance cognitive recovery for young cancer survivors.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on cancer-related treatments, it will be discussed with the study team to see if it affects your participation.
What prior data suggests that this adaptive attention training is safe for pediatric cancer survivors?
Research has shown that programs like the new mindful attention training being tested can improve focus, memory, and thinking skills in children who have survived cancer. This training is generally easy to manage, as it involves no medical procedures and resembles mental exercises. No serious side effects have been linked to these programs, suggesting the treatment is likely safe. However, individual reactions may vary. Participants should always consult the trial team with any questions or concerns.12345
Why are researchers excited about this trial?
Researchers are excited about Mindful Attention Training for pediatric cancer survivors because it offers a novel approach to improving attention and cognitive function, which can be affected by cancer and its treatments. Unlike traditional therapies that might focus on medication or cognitive rehabilitation, this method provides an at-home, adaptive training program that is both accessible and engaging for young patients. By allowing participants to complete the training at their own pace over 6-8 weeks, it empowers them to actively participate in their recovery process, potentially enhancing their quality of life with minimal disruption to their daily routines.
What evidence suggests that this trial's treatments could be effective for pediatric cancer survivors?
Research has shown that mindful attention training can improve thinking and behavior in cancer survivors. In this trial, participants will join different treatment arms to evaluate the effectiveness of this training. Studies have found that this type of cognitive training can boost brain function in cancer survivors. Mindfulness-based programs also reduce stress and anxiety, common among cancer survivors. This training may help people focus better and reduce mental distractions, potentially improving thinking skills. Early evidence suggests these non-drug methods hold promise for enhancing the quality of life in children who have survived cancer.12367
Who Is on the Research Team?
Joaquin Anguera, PhD
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for children aged 7-17 who have survived pediatric cancer, can follow the study's procedures, and have a guardian to consent. They should speak English fluently, not be on certain cancer treatments that affect participation, and must have had radiation therapy to the brain or neck.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants complete adaptive attention training ('Engage') for 6-8 weeks, with randomized cohorts completing either 15 hours or 1 hour of training.
Follow-up
Participants are monitored for cognitive and behavioral outcomes after completing the training.
No Contact Group Assessment
Participants in the no-contact group complete baseline and end-of-study assessments to evaluate assessment feasibility and reliability.
What Are the Treatments Tested in This Trial?
Interventions
- Novel Mindful Attention Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor